Comparison of ThinPrep and SurePath Liquid‐based Cytology and Subsequent Human Papillomavirus DNA Testing in China

Fang-Hui Zhao,Shang-Ying Hu,Jessica J. Bian,Bin Liu,Roger B. Peck,Yan-Ping Bao,Qin-Jing Pan,Lucien Frappart,John Sellors,You-Lin Qiao
DOI: https://doi.org/10.1002/cncy.20177
2011-01-01
Cancer Cytopathology
Abstract:BACKGROUND: Liquid-based cytology (LBC) has been compared with conventional cytology in numerous studies. In the current study of 2 LBC systems, the accuracy, rates of unsatisfactory cytology, and sufficiency of residual LBC specimens for Hybrid Capture 2 (HC2) HPV DNA testing were compared. METHODS: Eligible women ages 30 to 49 years were recruited for this cross-sectional population-based study in rural China. Women were assessed by visual inspection with acetic acid (VIA), LBC, and high-risk HPV HC2 DNA assay. Cervical specimens were preserved according to Sure Path or Thin Prep protocols. LBC results were manually read. HC2 testing was performed on specimens with sufficient residual volume. Colposcopies and biopsies were performed on women who were VIA positive at the time of initial screening. Women with abnormal LBC or HC2 test results were called back for colposcopies and 4-quadrant cervical biopsies. RESULTS: Of 2005 eligible women, 972 were tested by Sure Path and 1033 by Thin Prep. Compared with Sure Path samples, Thin Prep samples had higher rates of unsatisfactory cytology (0.2% for Sure Path and 1.5% for Thin Prep) and insufficient residual volume for HC2 (0.0% for Sure Path and 18.2% for Thin Prep). Sure Path samples yielded higher sensitivities and similar specificities for LBC and HC2 testing of residual specimens, but these differences were not determined to be significant by area-under-the-curve analysis (LBC performance: 0.89 for Sure Path and 0.85 for Thin-Prep; HC2 performance: 0.91 for Sure Path and 0.89 for Thin Prep). CONCLUSIONS: Both methods yielded similar validity in detecting significant cervical lesions. However, Sure Path samples yielded higher rates of satisfactory LBC slides and sufficient residual volume for HC2. Cancer (Cancer Cytopathol) 2011;119:387-94. (C) 2077 American Cancer Society.
What problem does this paper attempt to address?